US2023263862A1PendingUtilityA1
Formation of bone
Assignee: ALLERGAN PHARMACEUTICALS INT LTDPriority: Sep 1, 2015Filed: Mar 14, 2023Published: Aug 24, 2023
Est. expirySep 1, 2035(~9.1 yrs left)· nominal 20-yr term from priority
A61K 38/39A61K 9/0019A61K 9/06A61P 19/00A61P 19/08
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for inducing or promoting repair of a bone fracture.
Claims
exact text as granted — not AI-modified1 . A method of inducing formation of bone in an individual including the step of
providing an individual requiring bone formation, providing a therapeutically effective amount of tropoelastin to the individual to induce the formation of bone in the individual, thereby inducing bone formation in the individual.
2 . The method of claim 1 wherein the individual has a bone defect in which bone formation is required.
3 . The method of claims 1 or 2 wherein the defect is a fracture or void.
4 . The method of claim 3 wherein the defect is a fracture and the individual is provided with tropoelastin to promote the repair of the fracture.
5 . The method of claim 4 wherein the tropoelastin is administered directly to bone at the site of the fracture.
6 . The method of any one of the preceding claims wherein the tropoelastin is administered directly to the bone callus.
7 . The method of any one of the preceding claims wherein the tropoelastin is administered by injection.
8 . The method of claim 6 wherein the tropoelastin is administered in the form of a gel, putty or paste.
9 . The method of claim 8 wherein the tropoelastin is administered to a periosteal surface.
10 . The method of claim 3 wherein the defect is a void.
11 . The method of claim 10 wherein the tropoelastin is administered directly to bone at the site of the bone void.
12 . The method of claim 11 wherein the tropoelastin is administered directly to the bone callus.
13 . The method of claim 12 wherein the tropoelastin is administered by injection.
14 . The method of claim 13 wherein the tropoelastin is administered in the form of a gel, putty or paste.
15 . The method of claim 14 wherein the tropoelastin is administered to a periosteal surface.
16 . The method of claim 2 wherein the bone defect is low bone density.
17 . The method of claim 16 wherein the tropoelastin is administered to a periosteal surface.
18 . The method of claim 16 wherein the tropoelastin is administered to an endosteum region.
19 . The method of claim 18 wherein the tropoelastin is administered to an endosteum region by micro-drilling of cortical bone.
20 . A method of any one of the preceding claims wherein the tropoelastin is SHELδ26A, as shown in SEQ ID NO: 1.Join the waitlist — get patent alerts
Track US2023263862A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.